Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Eva Tiensuu Janson¹, Ulrich Knigge², Gitte Dam³, Birgitte Federspiel⁴, Henning Grønbaek³, Peter Stålberg⁵, Seppo W Langer^{6

7}, Andreas Kjaer^{8

9}, Johanna Arola¹⁰, Camilla Schalin-Jäntti¹¹, Anders Sundin¹², Staffan Welin¹, Espen Thiis-Evensen¹³, Halfdan Sorbye^{14

15}

Affiliations

¹ Department of Medical Sciences, Endocrine Oncology Uppsala University, Uppsala, Sweden.
² Departments of Surgery C and Endocrinology PE, Faculty of Health Science, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
³ Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
⁴ Department of Pathology, Faculty of Health Science, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
⁵ Department of Surgical Sciences, Endocrine Surgery, Uppsala University, Uppsala, Sweden.
⁶ Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
⁷ Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
⁸ Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet, Copenhagen, Denmark.
⁹ Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
¹⁰ Department of Pathology, HUSLAB, Helsinki University and Helsinki University Central Hospital, Helsinki, Finland.
¹¹ Endocrinology, Abdominal Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
¹² Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
¹³ Department for Organ Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
¹⁴ Department of Oncology, Haukeland University Hospital, Bergen, Norway.
¹⁵ Department of Clinical Medicine, University of Bergen, Bergen, Norway.

PMID: 33999752
DOI: 10.1080/0284186X.2021.1921262

Free article

Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Eva Tiensuu Janson et al. Acta Oncol. 2021 Jul.

Free article

. 2021 Jul;60(7):931-941.

doi: 10.1080/0284186X.2021.1921262. Epub 2021 May 17.

Authors

Affiliations

¹ Department of Medical Sciences, Endocrine Oncology Uppsala University, Uppsala, Sweden.
² Departments of Surgery C and Endocrinology PE, Faculty of Health Science, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
³ Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
⁴ Department of Pathology, Faculty of Health Science, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
⁵ Department of Surgical Sciences, Endocrine Surgery, Uppsala University, Uppsala, Sweden.
⁶ Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
⁷ Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
⁸ Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet, Copenhagen, Denmark.
⁹ Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
¹⁰ Department of Pathology, HUSLAB, Helsinki University and Helsinki University Central Hospital, Helsinki, Finland.
¹¹ Endocrinology, Abdominal Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
¹² Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
¹³ Department for Organ Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
¹⁴ Department of Oncology, Haukeland University Hospital, Bergen, Norway.
¹⁵ Department of Clinical Medicine, University of Bergen, Bergen, Norway.

PMID: 33999752
DOI: 10.1080/0284186X.2021.1921262

Abstract

Background: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.

Aim: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.

Keywords: ;; Diagnosis; neuroendocrine carcinoma; neuroendocrine tumour; treatment.

PubMed Disclaimer

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Affiliations

Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Authors

Affiliations

Abstract

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical